Home NDC 13668-515
acyclovir
Product NDC 13668-515
11-digit product format 136680515
Labeler code 13668
Product ID 13668-515_95f260b9-dd7f-4bd5-af7e-c4f4671ac6bd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acyclovir
Dosage form OINTMENT
Route TOPICAL
Labeler Torrent Pharmaceuticals Limited
Application ANDA209971
Marketing category ANDA
Marketing start 2019-01-11
Substance ACYCLOVIR
Active strength 50 mg/g
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base acyclovir
Listing expiration 2026-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 50 mg/g
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197312
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 13668-515-01 acyclovir 15 g in 1 TUBE OINTMENT 15 9 13668-515-02 acyclovir 30 g in 1 TUBE OINTMENT 30 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 13668-515 ACYCLOVIR OINTMENT [TORRENT PHARMACEUTICALS LIMITED] 9 Current NDC, Legacy NDC, 2 package rows 20250119_1c510390-fb00-4271-967d-0883a9d5e1fd.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 13668-515-01 13668051501 15 g in 1 TUBE (13668-515-01) 15 g 2019-01-11 0000-00-00 No No Current 13668-515-02 13668051502 30 g in 1 TUBE (13668-515-02) 30 g 2019-01-11 0000-00-00 No No Current